Psoriatic Arthritis: Depressing News on Second- and Later-Line Treatments Real-world data indicate most patients who fail a first biologic drug never obtain remission Feb 27, 2023
Study Suggests Path Connecting Periodontal Disease With Rheumatoid Arthritis Exposing immune system to citrullinated bacterial proteins seen as trigger Feb 22, 2023
Taltz Safety, Efficacy Stay Robust in Spondyloarthritis at 3 Years Benefits appear durable for patients in a long-term extension Feb 21, 2023
Wearable Sensors Show Promise for Remote OA Assessment Provide good data and most patients can manage them, small trial indicates Feb 06, 2023
Rheumatoid Factor and ACPA, Meet Potential New Partners for RA Diagnosis Additional autoantibodies found to improve sensitivity in early-stage disease Feb 02, 2023
Mileage Varies for Different Hip Surgery Approaches No single "best" in meta-analysis, though a clear loser emerges Jan 31, 2023
Blood Test Bests Standard OA Prognostic Models in Early Study Multi-marker panel does a better job of predicting who will show rapid progression Jan 25, 2023
In Knee OA, Exercise Is Helpful ... But Maybe More in Mind Than Body Trial shows little extra benefit from intensive program Jan 23, 2023
JAK Inhibitor Promising for Polymyalgia Rheumatica Oral drug seen as safer than chronic, high-dose steroids Jan 09, 2023
Why Doesn't Exercise Help Everyone With Knee OA? Actually, the better question is why can't everyone do the recommended exercises Jan 04, 2023
Early OA Common in Military Officers After Knee Injury Many show joint degradation before age 30 Dec 20, 2022
Metformin Protective Against Joint Replacement in Type 2 Diabetes Daily users saw lower risks for total knee, hip replacements Dec 19, 2022
It's a TNF Inhibitor! It's a Steroid! It's Two (Potential) RA Drugs in One! Hints in mid-stage trial that novel conjugate will surpass adalimumab in efficacy Dec 14, 2022
Joint Pain Linked to Worse Quality of Life in Ulcerative Colitis Patients Pain tied to increased risks of depression, anxiety, fatigue, and social impairment Dec 08, 2022
Xeljanz Cancer Risks Detailed New paper provides full results from ORAL Surveillance trial Dec 07, 2022
Not Just a Miner's Problem: Workplace Fumes, Dust Tied to RA Swedish study expands range of airborne toxics associated with rheumatic disease Dec 06, 2022
Cardiovascular Risk Marker Improved With Common Rheumatoid Arthritis Drugs Benefit seen with conventional DMARDs as well as biologics Dec 02, 2022
Common Treatments for Knee Osteoarthritis May Be Harmful Steroids and NSAIDs reduced pain but not disease course, studies showed Nov 30, 2022
Study: New Moms Need Not Worry About Enbrel in Breast Milk Present in small amounts, but infants apparently unaffected in small sample Nov 28, 2022
Bone Drug Reverses Damage in Hand Osteoarthritis Provocative findings with denosumab, but don't reach for the prescription pad just yet Nov 15, 2022
Two Surgery Types Yield Similar Results in Advanced Ankle Osteoarthritis Similar clinical scores with either total ankle replacement or fusion surgery, trial shows Nov 14, 2022
Checkpoint Stimulator Passes Mid-Stage Test in Rheumatoid Arthritis Novel approach to normalizing immune activity Nov 14, 2022
Another Adalimumab Biosimilar Seems Set for Interchangeability Trial data pave way for FDA approval Nov 14, 2022
Want a Few Weeks of Knee Pain Relief? Try This Local nerve block proves mettle in randomized trial, though benefit didn't last long Nov 12, 2022
Chronic Pain: Opioids No Longer Treatment of Choice Nondrug therapies increased markedly in wake of 2016 CDC guidance Nov 07, 2022
New ACR/EULAR Guideline Expands RA Remission Definition Axial spondyloarthritis guidance also gets an update Oct 25, 2022
Does Rheumatoid Arthritis Get Its Start in the Gut? Patients and at-risk individuals show antibodies to common intestinal bacterium Oct 20, 2022
Notes From Underground: Miners Face Increased Risk of Rheumatoid Arthritis Silica exposure seen responsible Oct 17, 2022
Is PMR the Next Indication for Tocilizumab? Phase III data suggest yes, albeit in a limited population and with several cautions Sep 20, 2022
Predicting Fractures in RA: Is FRAX Useful in the Modern Treatment Era? Algorithm held its own, but not many study patients were on biologics Sep 11, 2022
Mixed Results for Novel Lupus Drug in Mid-Stage Trial Developer of litifilimab, an anti-BDCA2 antibody, presses ahead despite phase II hiccups Sep 07, 2022
Pirfenidone Shows Hints of Benefit for RA-Related Lung Disease But early halt to recruitment, forced by pandemic, left trial underpowered Sep 06, 2022
Novel IL-6 Blocker Matches Humira in Rheumatoid Arthritis But is Russian backing a problem for U.S. approval? Aug 24, 2022
Study: Don't Assume Spinal Findings on MRI Signify Spondyloarthritis Many healthy people also show sacroiliac and spine lesions Jul 19, 2022
Lubricant Shots for Knee OA: No, They Really Don't Help Meta-analysis of hyaluronic acid trials throws serious shade on common practice Jul 06, 2022
Trial: Rinvoq Effective for Biologic-Refractory Ankylosing Spondylitis Data helped drug to gain recent label expansion Jul 05, 2022
Novel Anti-TNF Shines in Rheumatoid Arthritis Trial Trivalent "nanobody" biologic engineered to accumulate in inflamed tissue Jun 24, 2022
